Clinical trial
The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients…
NCT03631225 · Sequenom, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT03631225 |
|---|---|
| Title | The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis |
| Official title | Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis |
| Lead sponsor | Sequenom, Inc., Industry |
| Collaborators | Laboratory Corporation of America Industry |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis (RA) |
| Intervention type | Diagnostic Test |
| Interventions | Vectra |
| Enrollment | 1,500 |
| Start date | Jun 25, 2019 |
| Primary completion | Feb 1, 2026 |
| Completion | Apr 15, 2026 |
| First posted | Aug 15, 2018 |
| Last update posted | Nov 6, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: